Callistemon viminalis

Connections displayed (default: 10).

Phytochemicals :

Diseases :

Formulations :

Loading graph...

ℹ️ Click here to know more about the properties

Scientific Name	Callistemon viminalis
Database Name	cmaup_plants
Synonyms	Callistemon Viminalis
Ipni Id	591427-1
Plant Name	Callistemon Viminalis
Genus Tax Id	73722
Disease Name	Insomnia, Pain, unspecified, Acute/subacute hepatic failure, Crohn disease, Asthma, Diabetes mellitus, type unspecified, Attention deficit hyperactivity disorder, Muscular dystrophy, Inborn lipid metabolism error, Solid tumour/cancer, Depression, Migraine, Rheumatoid arthritis, Functional bladder disorder, Fungal infection, Cannabis use disorder, Obesity, Hypo-thyroidism, Acute diabete complication, Nausea/vomiting, Opioid use disorder, Atopic eczema, Nicotine use disorder, Lupus erythematosus, Multiple sclerosis, Knee osteoarthritis, Indeterminate colitis, Type 2 diabetes mellitus, General pain disorder, Acute myeloid leukaemia, Colorectal cancer, Irritable bowel syndrome, Choreiform disorder, Anorexia nervosa, Urinary tract infection, Psoriasis, Skin and skin-structure infection, Visual system disease, Chronic kidney disease, Lower limb mononeuropathy, Chronic pain, Osteoarthritis, Thyroid cancer, Substance abuse, Metabolic disorder, Clostridium difficile enterocolitis, Other specified disorders of carbohydrate absorption or transport, Bacteraemia, Endocarditis, Pre-eclampsia, Bipolar disorder, Cystic fibrosis, Gram-positive bacterial infection, Herpes simplex infection, Non-small cell lung cancer, Sepsis, Mental/behavioural/neurodevelopmental disorder, coronary artery disease, Pulmonary hypertension, COVID-19, Osteomyelitis or osteitis, Other specified conjunctivitis, Argininosuccinic aciduria, Diabetic foot ulcer, Chronic rhinosinusitis, Pneumonia, Allergic/hypersensitivity disorder, Prostate cancer, Ischaemic heart diseases, unspecified, Cardiovascular disease, Skin disease, Malignant haematopoietic neoplasm, Bacterial infection, Chronic arterial occlusive disease, unspecified, Graft-versus-host disease, Autism spectrum disorder, Other specified pyogenic bacterial infection of skin and subcutaneous tissue, Disorders of methionine cycle or sulphur amino acid metabolism, Cataract, Ulcerative colitis, Bacterial pneumonia, Neoplasms, Nosocomial, Cardiac arrest, Inflammatory arthropathy, Hepatocellular carcinoma, NOS, Macular degeneration, Staphylococcal/streptococcal disease, Periodontal disease, Beta thalassaemia, Sickle-cell disorder, Intermediate hyperglycaemia, unspecified, Myocardial infarction, Diarrhoea, Primary sclerosing cholangitis, Bacterial cellulitis, erysipelas or lymphangitis, Xerostomia, Mature T-cell lymphoma, Sepsis of fetus or newborn, Hepatic fibrosis/cirrhosis, Essential hypertension, Pyogenic abscess of the skin, Dental caries, Pneumonia due to Staphylococcus, Malignant neoplasm metastasis, unspecified, Duchenne muscular dystrophy, Alcoholic hepatitis, Ventilation associated with injury or harm in therapeutic use, Congestive heart failure, Galactose-1-phosphate uridyltransferase deficiency, Malaria, Schizophrenia, Melasma, Kidney failure, Peritonitis, Alzheimer disease, Tuberculosis of the respiratory system, Glioblastoma, primary, NOS, Small cell carcinoma of bronchus or lung, Constipation, Structural developmental anomaly of heart or great vessels, unspecified, Carcinosarcoma of uterus, Coeliac disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Myelodysplastic syndromes, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Adenocarcinoma of stomach, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Myotonic dystrophy, Other specified malignant neoplasms of kidney, except renal pelvis, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Other specified malignant neoplasms ofcolon, Hepatocellular carcinoma of liver, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Adenocarcinoma of prostate, Malignant neoplasms of stomach, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Malignant neoplasms of thymus, Invasive carcinoma of breast, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Malignant neoplasms of adrenal gland, Gliomas of brain
Species Name	Callistemon viminalis
Genus Name	Callistemon
Species Tax Id	73737
Disease Id	7A00-7A0Z, MG3Z, DB91, DD70, CA23, 5A14, 6A05, 8C70, 5C52, 2A00-2F9Z, 6A70-6A7Z, 8A80, FA20, GC50, 1F29-1F2F, 6C41, 5B80-5B81, 5A00, 5A2Y, MD90, 6C43, EA80, 6C4A, 4A40, 8A40, FA01, DD72, 5A11, 8.00E+43, 2A60, 2B91, DD91, 8A01, 6B80, GC08, EA90, 1F28-1G0Z, 9E1Z, GB61, 8C11, MG30, FA00-FA05, 2D10, 6C40, 5C50-5D2Z, 1A04, 5C61.Y, MA15.0, BB40-BA42, JA24, 6A60, CA25, 1B74-1F40, 1F00, 2C25, 1G40-1G41, 6E20-6E8Z, BA8Y-BA8Z, BB01, 1D6Y, FB84, 9A60.Y, 5C50.A0, BD54, CA0A, CA40, 4A80-4A8Z, 2C82, BA6Z, BA00-BE2Z, EA00-EM0Z, 2B33, 1A00-1C4Z, BD4Z, 4B24, 6A02, 1B7Y, 5C50.B, 9B10, DD71, CA40.0, 2, XB25, MC82, FA2Z, XH4W48, 9B75, 1B5Y, DA0C, 3A50.2, 3A51, 5A40.Z, BA41-BA43, ME05.1, DB96.2, 1B70, DA02.1, 2A90, KA60, DB93, BA00, 1B75.3, DA08.0, CA40.06, 2E2Z, 8C70.1, DB94.1, PK81.0, BD10, 5C51.40, 1F40-1F45, 6A20, ED60.1, GB60-GB6Z, DC50, 8A20, 1B10, XH0MB1, 2C25.1, ME05.0, LA8Z, 2C76.43, DA95, 2C73.4, XH3854, 2A3Z, 2C15, 2C12.01, 1F54, 2B72.0, 2D60.0, 2A81, 8C71.0, 2C90.Y, 2C25.2, 1D46, 2C10.0, 2C26.0, 2B90.Y, 2C12.02, GA10.B4, 2B70, 2C94.2, 1D82, 2C82.0, 2B72, 2C25.0, 2C76.Z, 2C27, 2C61, 1C62, 2A00.00, XH6153, 2C80.2, 2D11, 2A00.0
Family Name	Myrtaceae
Family Tax Id	3931

1. (+)-Stephacidin A (PubChem CID: 16127922)
2. (1r)-3,5,5-Trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-Tetramethyl-18-[(1r)-2,6,6-Trimethylcyclohex-2-En-1-Yl]octadeca-3,5,7,9,11,13,15,17-Octaen-1-Ynyl]cyclohex-3-En-1-Ol (PubChem CID: 101289802)
3. (1r,2r)-2-[(1e,3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15-Octaen-17-Ynyl]-1,3,3-Trimethylcyclohexane-1,2-Diol (PubChem CID: 163014206)
4. (1s,3ar,3bs,5ar,6r,8as,8bs)-3a,5a-Dimethyl-6-[(E,2r,5s)-5-Methylhept-3-En-2-Yl]-1,2,3,3b,4,5,6,7,8,8a,8b,9-Dodecahydroindeno[5,4-E]inden-1-Ol (PubChem CID: 163076709)
5. (1s,4r,4as,6r)-4,4a-Dimethyl-6-Prop-1-En-2-Yl-2,3,4,5,6,7-Hexahydro-1h-Naphthalen-1-Ol (PubChem CID: 44576208)
6. (2r)-2-[(2s,5r,9s)-2-[(S)-[(2r,5r)-5-[(1s,3r,5s)-1-[(2r,5r)-5-[(2r,3e,5e)-6-[(2r,3r,5s)-5-[(2r,3r,4r)-2-Hexadecanoyloxy-3-Hydroxy-4-Methyloxan-2-Yl]-3-Hydroxyoxolan-2-Yl]-2,4-Dimethylhexa-3,5-Dienyl]-5-Methyloxolan-2-Yl]-5-Methyl-2,8-Dioxabicyclo[3.2.1]octan-3-Yl]-2-Methyl-4-Oxooxolan-2-Yl]-Hydroxymethyl]-1,10-Dioxaspiro[4.5]decan-9-Yl]propanoic Acid (PubChem CID: 163101767)
7. (2r)-3-[(2s,6r,8r,11r)-2-[(E,2r)-4-[(2s,2'r,4r,4ar,6r,8as)-2-[(1s,3s)-1,3-Dihydroxy-3-[(2s,3r,6s)-3-Methyl-1,7-Dioxaspiro[5.5]undecan-2-Yl]propyl]-4-Hydroxy-3-Methylidenespiro[4a,7,8,8a-Tetrahydro-4h-Pyrano[3,2-B]pyran-6,5'-Oxolane]-2'-Yl]but-3-En-2-Yl]-11-Hydroxy-4-Methyl-1,7-Dioxaspiro[5.5]undec-4-En-8-Yl]-2-Hydroxy-2-Methylpropanoic Acid (PubChem CID: 163088763)
8. (2s,3s,4s)-4-[(2e,4z,6s)-6-Carboxyhepta-2,4-Dien-2-Yl]-3-(Carboxymethyl)pyrrolidine-2-Carboxylic Acid (PubChem CID: 162916711)
9. (2s,3s,4s)-4-[(2z,4z,6s)-6-Carboxyhepta-2,4-Dien-2-Yl]-3-(Carboxymethyl)pyrrolidine-2-Carboxylic Acid (PubChem CID: 162916712)
10. (2z,4e,6e,8e,10e,12e,14e,16e)-3-Hydroxy-19-[(4s)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-1-[(1r,4s)-4-Hydroxy-1,2,2-Trimethylcyclopentyl]-4,8,13,17-Tetramethylnonadeca-2,4,6,8,10,12,14,16-Octaen-18-Yn-1-One (PubChem CID: 162912290)
11. (3r,3'r)-3'-(3-Hydroxyphenyl)-4-Methylspiro[1h-1,4-Benzodiazepine-3,2'-Oxirane]-2,5-Dione (PubChem CID: 92278353)
12. (3r,5s)-5-[(1r,4s,6r,7s,9r,10e,12r,17r,19r,20s,29s,32s)-9,32-Dihydroxy-6,10,13,19,20,32-Hexamethyl-27-Methylidene-33,34,35-Trioxa-22-Azahexacyclo[27.3.1.11,4.14,7.012,17.017,23]pentatriaconta-10,13,22-Trien-14-Yl]-3-Methyloxolan-2-One (PubChem CID: 162927161)
13. (3r,5s)-5-[(1s,4s,6s,7r,9r,10e,12s,17r,20r,29s,32s)-9,32-Dihydroxy-6,10,13,20,32-Pentamethyl-27-Methylidene-33,34,35-Trioxa-22-Azahexacyclo[27.3.1.11,4.14,7.012,17.017,23]pentatriaconta-10,13,22-Trien-14-Yl]-3-Methyloxolan-2-One (PubChem CID: 163190285)
14. (3s,8as)-3-[[(3r)-7,7-Dimethyl-3-(2-Methylbut-3-En-2-Yl)-2-Oxo-1h-Pyrano[2,3-G]indol-3-Yl]methyl]-2,3,6,7,8,8a-Hexahydropyrrolo[1,2-A]pyrazine-1,4-Dione (PubChem CID: 16127840)
15. (3s,8as)-3-[[2-(2,2-Dimethylbut-3-Enyl)-1h-Indol-3-Yl]methyl]-2,3,6,7,8,8a-Hexahydropyrrolo[1,2-A]pyrazine-1,4-Dione (PubChem CID: 163091236)
16. (4as,7s)-7-Hydroxy-1,4a-Dimethyl-7-Prop-1-En-2-Yl-4,5,6,8-Tetrahydro-3h-Naphthalen-2-One (PubChem CID: 57335617)
17. (4as,9bs)-1,7,9b-Trihydroxy-4a,9-Dimethoxy-6-(3-Methylbutanoyl)-2-(2-Methylpropanoyl)-4h-Dibenzofuran-3-One (PubChem CID: 155550448)
18. (4r,5r)-4-Hydroxy-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyl-2-Oxooctadeca-3,5,7,9,11,13,15-Heptaen-17-Ynyl]-3,3,5-Trimethylcyclohexan-1-One (PubChem CID: 23428074)
19. (4r,5r)-4-Hydroxy-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4s)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyl-2-Oxooctadeca-3,5,7,9,11,13,15-Heptaen-17-Ynyl]-3,3,5-Trimethylcyclohexan-1-One (PubChem CID: 162865461)
20. (5z)-5-((2e,4e,6e,8e)-11-((4r)-4-Hydroxy-2,6,6-Trimethyl-1-Cyclohexen-1-Yl)-2,9-Dimethyl-2,4,6,8-Undecatetraen-10-Yn-1-Ylidene)-3-((1e)-2-((1s,4s,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo(4.1.0)hept-1-Yl)ethenyl)-2(5h)-Furanone (PubChem CID: 134741793)
21. (5z)-5-[(2e,4e,6e)-9-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-7-Methylnona-2,4,6-Trien-8-Ynylidene]-3-[(E)-2-[(1r,2r,4s)-1,2,4-Trihydroxy-2,6,6-Trimethylcyclohexyl]ethenyl]furan-2-One (PubChem CID: 162883665)
22. (5z)-5-[(2e,4e,6e)-9-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-7-Methylnona-2,4,6-Trien-8-Ynylidene]-3-[(E)-2-[(1s,4s,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo[4.1.0]heptan-1-Yl]ethenyl]furan-2-One (PubChem CID: 162880763)
23. (5z)-5-[(2e,4e,6e,8e)-11-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-2,9-Dimethylundeca-2,4,6,8-Tetraen-10-Ynylidene]-3-[(E)-2-[(1s,2s,4r)-1,2,4-Trihydroxy-2,6,6-Trimethylcyclohexyl]ethenyl]furan-2-One (PubChem CID: 162896470)
24. (S)-2,3-Dihydro-5,7-Dihydroxy-8-Methyl-2-Phenyl-4-Benzopyrone (PubChem CID: 6453244)
25. 1-Tridecene-3,5,7,9,11-Pentayne (PubChem CID: 441552)
26. 11,11-Dihydroxysaxitoxin (PubChem CID: 102411284)
27. 11beta-Hydroxy-N21-Sulfocarbamoylsaxitoxin (PubChem CID: 136045808)
28. 13-Hydroxy-14-Oxocacalohastin (PubChem CID: 637824)
29. 19'-Hexanoyloxyisomytiloxanthin (PubChem CID: 16061209)
30. 3,3'-Methylenebis(Tyrosine) (PubChem CID: 3082144)
31. 5-Hydroxy-3-Methoxy-4,4-Dimethyl-2-(3-Methylbutanoyl)cyclopent-2-En-1-One (PubChem CID: 155522062)
32. 7-Dehydrocholesterol (PubChem CID: 439423)
33. 7-Epi-Teucrenone B (PubChem CID: 57393409)
34. 8-Demethyleucalyptin (PubChem CID: 15715157)
35. [(2s,3r,4s,5r,6s)-6-[5,7-Dihydroxy-2-(4-Hydroxyphenyl)-4-Oxochromen-3-Yl]oxy-3,4,5-Trihydroxyoxan-2-Yl]methyl (4r)-4-(2-Hydroxypropan-2-Yl)cyclohexene-1-Carboxylate (PubChem CID: 162849269)
36. [(5s)-4-Formyl-9-Methoxy-5-Methyl-5,6-Dihydrobenzo[F][1]benzofuran-3-Yl]methyl Acetate (PubChem CID: 44566461)
37. Abietatriene (PubChem CID: 6432211)
38. Alloxanthin (PubChem CID: 6443740)
39. Alpha-Pinene, (+)- (PubChem CID: 82227)
40. Amarouciaxanthin B/sidnyaxanthin (PubChem CID: 16061221)
41. Anandamide (PubChem CID: 5281969)
42. Aspermytin A (PubChem CID: 9993091)
43. Azaspiracid-3 (PubChem CID: 131842452)
44. Beta-Carotene (PubChem CID: 5280489)
45. Beta-Sitosterol (PubChem CID: 222284)
46. Betaine (PubChem CID: 247)
47. Catalpalactone (PubChem CID: 3014018)
48. Cid 101396440 (PubChem CID: 101396440)
49. Cid 154735200 (PubChem CID: 154735200)
50. Cid 162860366 (PubChem CID: 162860366)
51. Cid 162883225 (PubChem CID: 162883225)
52. Cid 162887352 (PubChem CID: 162887352)
53. Cid 162913940 (PubChem CID: 162913940)
54. Cid 162985394 (PubChem CID: 162985394)
55. Cid 162999788 (PubChem CID: 162999788)
56. Cid 163014543 (PubChem CID: 163014543)
57. Cid 163032184 (PubChem CID: 163032184)
58. Cid 163076592 (PubChem CID: 163076592)
59. Cid 17753955 (PubChem CID: 17753955)
60. Cid 23428237 (PubChem CID: 23428237)
61. D-Galactose (PubChem CID: 6036)
62. Delta-Cadinol (PubChem CID: 3084311)
63. Domoic Acid C5'-Diastereomer (PubChem CID: 5311075)
64. Ergosterol (PubChem CID: 444679)
65. Eucalyptin (PubChem CID: 76573)
66. Halocynthiaxanthin (PubChem CID: 11966451)
67. Hexadecanoic Acid Propylamide (PubChem CID: 10379895)
68. Himeic Acid A (PubChem CID: 11774903)
69. Himeic Acid B (PubChem CID: 21579676)
70. Himeic Acid C (PubChem CID: 21777983)
71. Isodomoic Acid F (PubChem CID: 101790920)
72. Izalpinin (PubChem CID: 5318691)
73. Laurotetanine (PubChem CID: 31415)
74. Ligucyperonol (PubChem CID: 14681770)
75. Magnocurarine (PubChem CID: 53266)
76. Mytiloxanthin (PubChem CID: 11365423)
77. N,n,n-Trimethylglycinium (PubChem CID: 248)
78. Notoamide A (PubChem CID: 16128040)
79. Notoamide B (PubChem CID: 16127923)
80. Notoamide D (PubChem CID: 16127841)
81. Notoamide F (PubChem CID: 25180710)
82. Notoamide G (PubChem CID: 25180707)
83. Notoamide I (PubChem CID: 25180708)
84. Notoamide J (PubChem CID: 25180709)
85. Notoamide K (PubChem CID: 25180896)
86. Notoamide O (PubChem CID: 102043608)
87. Notoamide P (PubChem CID: 46919486)
88. Notoamide Q (PubChem CID: 46919487)
89. Notoamide R (PubChem CID: 46919488)
90. Nv766twa77 (PubChem CID: 102146782)
91. Oxyphyllenodiol A (PubChem CID: 10082923)
92. Pectenol A/(Pectenol) (PubChem CID: 16061215)
93. Pinosylvin Monomethyl Ether (PubChem CID: 5281719)
94. Sclerotiamide (PubChem CID: 10647785)
95. Vancomycin (PubChem CID: 14969)
96. Yakuchinone-A (PubChem CID: 133145)

Not listed in any formulations.

Back to Browse Back to Home

GRAYU Website

Grayu

Callistemon viminalis

Graph

Plant Properties

Associated Phytochemicals 96

Associated Diseases 27

Found In Formulations 0